
The Citrus Oncology team at the CancerX – Moffitt Innovation Summit
Citrus Oncology shared a post by Grace Cordovano, Co-Founder of Unblock Health, on LinkedIn:
“What an incredible experience at the CancerX – Moffitt Innovation Summit!
The Citrus Oncology team is deeply grateful to CancerX, Moffitt Cancer Center and all the partners and organizers who made this summit a hub for innovation, collaboration, and purpose-driven progress in cancer care.
It was an honor to be surrounded by visionary leaders, health tech innovators, and passionate advocates—all working to transform the future of oncology. We walked away inspired, empowered, and more committed than ever to our mission: improving access, outcomes, and quality of life for cancer patients through data-driven, value-based care.
Thank you, CancerX, for creating space for bold ideas and meaningful connections. We’re excited to keep building with this amazing community.”
Quoting Grace Cordovano‘s post:
“The CancerX Accelerator at Moffitt Innovation Summit called and boy did the event and team answer!
Key highlights included:
– Opening patient keynote with Dr Vondalyn Wright
– Patient Family Advisory Council (PFAC) in attendance
– Patient and carepartner unmet needs and voice strategically addressed throughout CancerX Accelerator program
– 16 Champion Ambassadors, including, Advocate Health, CEI VENTURES, INC., Dana-Farber Cancer Institute, Elevance Health, Flare Capital Partners, Healio, Innsena, Johnson and Johnson, Memorial Sloan Kettering Cancer Center, Nitera, Oncology Ventures, and new addition, cybersecurity experts, Clearwater
– Top 14 cutting-edge, digital health startups selected for our 2025 cohort, with touching personal stories describing their ‘why’, including AIQ Solutions, Arcascope, Citrus Oncology, Dyania Health, Encapsulate, Fifth Eye Inc., First Ascent Biomedical, Gabbi, Manta Cares, mPATH Health, nen, Recursive Health, We Are Here, Xploro.
– Cohort 1 Accelerator Alumni rallying in attendance
Key themes that crystallized:
– The patient voice is necessary in innovation and a driving force at CancerX
– Innovation = possibilities for patients
– Patients can’t wait. Time is of the essence.
– All patients and families living with cancer need access to digital health solutions where they are.
– Mentors and champions are committed and ready to help get solutions to patients.
– Relentless commitment to ending cancer as we know it.
Join us.”
Proceed to the video attached to the post.
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023